Trial Details

RECRUITING
Basic Information
Clinical ID c850
Identifier NCT05666960
Trial Title R-3750 in Patients with Mild to Moderate Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis Chronic Mild|Ulcerative Colitis Chronic Moderate|Ulcerative Colitis Chronic|Ulcerative Colitis
Interventions DRUG: R-3750
Participant Information
Sponsor Rise Therapeutics LLC
City Miami
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2023-02-27
Primary Completion Date 2025-09-25
Completion Date 2025-10-25